Phase 3 Clostridioides Difficile Infection Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
FMT Capsules for rCDI
FMTClostridioides Difficile Infection Recurrence
Helsinki University Central Hospital76 enrolled1 locationNCT07458984
Recruiting
Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting
Phase 2Phase 3
LMN-201 for Prevention of C. Difficile Infection Recurrence
Clostridioides Difficile Infection
Lumen Bioscience, Inc.375 enrolled16 locationsNCT05330182
Recruiting
Phase 2Phase 3
Secondary Prevention of Clostridioides Difficile Using Vancomycin
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06979609
Recruiting
Phase 3
Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence
Clostridioides Difficile Infection
Benoit Guery220 enrolled7 locationsNCT05266807
Recruiting
Phase 3
Gut Bugs for C. Difficile Infection
Recurrent Clostridioides difficile infectionFirst episode Clostridioides difficile infectionRefractory Clostridioides difficile infection
University of Auckland84 enrolled1 locationACTRN12624000133538